Evidence map›Paper›PMID 23637308›Full record

ReviewCold Spring Harbor perspectives in medicine2013

Chlamydial intracellular survival strategies.

Robert J Bastidas, Cherilyn A Elwell, Joanne N Engel, Raphael H Valdivia

Abstract readReview
In one paragraph

Review in Cold Spring Harbor perspectives in medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 131 papers.

0numbers the graph read from it
0cells of the map it votes in
131citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

131 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Kaempferol inhibitsFrontiers in microbiology · 2026
    Article
  7. Frontiers in cellular and infection microbiology · 2026
    Review
  8. Article
  9. Article
  10. mBio · 2025
    Article
  11. Article
  12. Current Evidence of Maternal Infection With Chlamydia trachomatis and Preeclampsia Risk.American journal of reproductive immunology (New York, N.Y. : 1989) · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Virulence · 2024
    Review
  17. Review
  18. mSphere · 2024
    Article
  19. Review
  20. Article

71 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Robert J BastidasDepartment of Molecular Genetics and Microbiology, Center for Microbial Pathogenesis, Duke University Medical Center, Durham, NC 27710, USA.
Cherilyn A Elwell
Joanne N Engel
Raphael H Valdivia

Funding

Novel approaches to identify host genes required for Chlamydia pathogenesisR01AI073770 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ENGEL, JOANNE N. · 2007 to 2016
$3.8M
Chlamydia Effector ProteinsR01AI081694 · NIAID · DUKE UNIVERSITY · PI VALDIVIA, RAPHAEL H · 2010 to 2014
$1.9M
NIAID NIH HHS R01 AI07377NIAID NIH HHS R01 AI073770NIAID NIH HHS R01 AI081694NIAID NIH HHS R01AI081694NIAID NIH HHS R01AI081694-S1
6 · The paper itself

Abstract

Chlamydia trachomatis is the most common sexually transmitted bacterial pathogen and the causative agent of blinding trachoma. Although Chlamydia is protected from humoral immune responses by residing within remodeled intracellular vacuoles, it still must contend with multilayered intracellular innate immune defenses deployed by its host while scavenging for nutrients. Here we provide an overview of Chlamydia biology and highlight recent findings detailing how this vacuole-bound pathogen manipulates host-cellular functions to invade host cells and maintain a replicative niche.

Indexed as

AnimalsApoptosisChlamydia InfectionsChlamydia trachomatisCytokinesEpithelial CellsGolgi ApparatusHost-Pathogen InteractionsHumansImmunity, InnateLife Cycle StagesMembrane Transport ProteinsCytokinesMembrane Transport Proteins

Identifiers

PMID23637308
PMCPMC3633179

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.